Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$22.17 - $51.8 $2.39 Million - $5.57 Million
107,583 Added 19.41%
661,883 $34.2 Million
Q2 2022

Aug 10, 2022

BUY
$15.36 - $27.51 $3.83 Million - $6.86 Million
249,434 Added 81.82%
554,300 $13.7 Million
Q1 2022

May 09, 2022

BUY
$22.22 - $39.12 $332,500 - $585,391
14,964 Added 5.16%
304,866 $7.64 Million
Q4 2021

Feb 09, 2022

BUY
$18.38 - $40.5 $5.08 Million - $11.2 Million
276,152 Added 2008.38%
289,902 $10.6 Million
Q3 2021

Nov 09, 2021

SELL
$13.18 - $19.83 $29,351 - $44,161
-2,227 Reduced 13.94%
13,750 $235,000
Q2 2021

Aug 10, 2021

SELL
$9.59 - $50.88 $94,988 - $503,966
-9,905 Reduced 38.27%
15,977 $213,000
Q1 2021

May 10, 2021

SELL
$49.53 - $68.4 $44,725 - $61,765
-903 Reduced 3.37%
25,882 $1.33 Million
Q4 2020

Feb 08, 2021

BUY
$47.25 - $65.16 $328,009 - $452,340
6,942 Added 34.98%
26,785 $1.66 Million
Q3 2020

Nov 06, 2020

SELL
$46.35 - $61.69 $5,562 - $7,402
-120 Reduced 0.6%
19,843 $1.09 Million
Q2 2020

Aug 05, 2020

BUY
$38.58 - $65.07 $221,449 - $373,501
5,740 Added 40.36%
19,963 $1.15 Million
Q1 2020

May 12, 2020

BUY
$32.73 - $50.78 $15,317 - $23,765
468 Added 3.4%
14,223 $571,000
Q4 2019

Feb 05, 2020

BUY
$6.81 - $39.55 $93,671 - $544,010
13,755 New
13,755 $544,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.